Filter posts

IP Sessions at BIO 2015: The Impact of the Inter Partes Review on (BIO)Pharma

The Intellectual Property Track at the BIO International Convention was a chance for IP thought …

Post-Convention Recap of BIO 2015: What the Official Bloggers Have to Say

Every day during the BIO International Convention our BIO Official Bloggers, writers who are on …

BIO Congratulates BioGENEius Winners!

The 2015 International BIO Convention brought together some of the top biotechnology experts from around …

Riding the Bull Market: What’s in Store for Biotech Dealmakers in 2015?

In many ways, 2014 was a record year for biopharma dealmaking, with $355 billion in …

The Next Step: How Companies Build Successful Therapeutic Franchises from the Ground Up

Building a new franchise in a therapeutic from scratch poses a host of challenges, from …

Closing-Day Recap of BIO 2015: What the Official Bloggers Have to Say

Everyday during the BIO International Convention our BIO Official Bloggers, writers who are on top …

Wednesday Recap of BIO 2015: What the Official Bloggers Have to Say

Everyday our BIO Official Bloggers, writers who are on top of the biotechnology beat, release …

Dr. Eric Topol's Insights on Wearables, Smart Phones, Digital Medicine Revolution

Dr. Eric Topol, director of the Scripps Translational Science Institute, is widely recognized for many …

Outdated Payments Systems Aren’t Keeping Pace With Medical Innovation

We are experiencing an era of rapid medical progress thanks to the accelerated pace at …

NIH Director Francis Collins Opens Day Two at BIO International Convention

What happens when a hotel loses Francis Collins’ room reservation late on the eve before …